← Eichor
Condition: Moderate Thrombocytopenia Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Moderate Thrombocytopenia

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

A Study of Selinexor Monotherapy in Subjects With JAK Inhibitor-naïve Myelofibrosis and Moderate Thrombocytopenia
Phase 2 · 70 location(s) · Karyopharm Therapeutics Inc · NCT05980806IgIV Plus Prednisone vs High-dose Dexamethasone for ITP
Phase 3 · 1 location(s) · Assistance Publique - Hôpitaux de Paris · NCT04968899Safety and Efficacy Study of PF-06835375 in Primary Immune Thrombocytopenia
Phase 2 · 31 location(s) · Pfizer · NCT05070845
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.